PEHA

Kesehatan

Phapros Tbk

Rp288-4(-1,37%)

Open: 294
High: 298
Low: 288
Prev: 292
Volume: 144 Rb
Nilai (est.): Rp 41,8 Jt

Jum, 25 Sep 2026O 294 H 298 L 288 C 288-1,37%Vol 144 Rb

RSI (14)48,38Netral

Ringkasan Teknikal

Netral

MA20

300

-3,90%

MA50

280

+2,73%

RSI(14)

48,38

0 · Oversold3070Overbought · 100

Harga vs MA20Di bawahBearish
Harga vs MA50Di atasBullish
MA20 vs MA50Golden (MA20 > MA50)Bullish
RSI(14)NetralNetral

Sinyal dihitung otomatis dari posisi harga terhadap moving average dan level RSI. Hanya sebagai referensi, bukan rekomendasi.

Kinerja Harga

1 Jam

-1,37%

1 Hari

-1,37%

1 Minggu

-0,69%

1 Bulan

+3,60%

3 Bulan

+11,63%

6 Bulan

+10,77%

1 Tahun

-10,56%

Sepanjang Masa

-84,00%

sejak Des 2018

Terendah 6BTertinggi 6B

206460

Data Fundamental

TTM · Yahoo Finance

Kapitalisasi Pasar: Rp 242 M
P/E Ratio: 6,00x
PBV: 0,57x
ROE: 9,59%
EPS: Rp 48,01
Nilai Buku / Saham: Rp 507
Dividend Yield: 1,74%
Saham Beredar: 840 Jt lbr

Tentang Perusahaan

PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also provides ethical generic and branded products; and medical devices, as well as toll manufacturing. It also exports its products. The company was founded in 1954 and is headquartered in Jakarta Selatan, Indonesia. PT Phapros Tbk is a subsidiary of PT Kimia Farma Tbk.

Rata-rata volume 20 hari: 1,84 Jt lembar

Saham Sejenis

Kesehatan